{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:50:18Z","timestamp":1790419818286,"version":"4.1.0"},"reference-count":52,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,15]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Men with Klinefelter syndrome (KS) develop hypergonadotropic hypogonadism, are in need of testosterone replacement therapy (TRT), and present with a more than 4-fold increased risk of thrombosis. TRT in KS has the potential to modify thrombotic risk, but data are scarce.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n To assess effects of 18 months of TRT on hemostasis in KS and identify genes associated with the prothrombotic phenotype.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Untreated and TRT-treated men with KS were included at baseline and matched to healthy controls. TRT was initiated in untreated KS and all groups were reassessed after 18 months of follow-up. Thrombin generation was evaluated with or without thrombomodulin, and fibrin clot lysis was evaluated by turbidity measurements. RNA expression was assessed in blood, fat, and muscle tissue of patients with TRT-treated KS and controls.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Thrombin generation with thrombomodulin was slightly increased in untreated KS, but overall KS was not associated with a hypercoagulable state. KS presented with fibrinolytic impairment associated with higher body fat and higher levels of fibrinogen. Eighteen months of TRT in KS was associated with a reduction in body fat and fibrinogen, attenuating the prothrombotic profile. The expression of ENPP4 was higher in men with KS and served as a key player among a group of genes associated with impaired fibrinolysis.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n KS is associated with a specific expression profile contributing to fibrinolytic impairment and increased thrombotic risk in the patients. TRT in patients with KS has the potential for alleviating the prothrombotic phenotype, in particular by reducing body fat and fibrinogen.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/clinem\/dgad658","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T18:42:42Z","timestamp":1699987362000},"page":"978-991","source":"Crossref","is-referenced-by-count":15,"title":["Testosterone Replacement Therapy in Klinefelter Syndrome\u2014Follow-up Study Associating Hemostasis and RNA Expression"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-3659","authenticated-orcid":false,"given":"Simon","family":"Chang","sequence":"first","affiliation":[{"name":"Unit for Thrombosis Research, University Hospital of Southern Denmark , 6700 Esbjerg , Denmark"},{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , 8200 Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-0000","authenticated-orcid":false,"given":"Jesper","family":"Just","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital , 8200 Aarhus , Denmark"},{"name":"Department of Clinical Medicine, Aarhus University , 8000 Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-4901","authenticated-orcid":false,"given":"Anne","family":"Skakkeb\u00e6k","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital , 8200 Aarhus , Denmark"},{"name":"Department of Clinical Medicine, Aarhus University , 8000 Aarhus , Denmark"},{"name":"Department of Clinical Genetics, Aarhus University Hospital , 8200 Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-7702","authenticated-orcid":false,"given":"Emma B","family":"Johannsen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital , 8200 Aarhus , Denmark"},{"name":"Department of Clinical Medicine, Aarhus University , 8000 Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5383-5501","authenticated-orcid":false,"given":"Jens","family":"Fedder","sequence":"additional","affiliation":[{"name":"Centre of Andrology and Fertility Clinic, Odense University Hospital , 5000 Odense , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-1720","authenticated-orcid":false,"given":"Claus H","family":"Gravholt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , 8200 Aarhus , Denmark"},{"name":"Department of Molecular Medicine, Aarhus University Hospital , 8200 Aarhus , Denmark"},{"name":"Department of Clinical Medicine, Aarhus University , 8000 Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-3977","authenticated-orcid":false,"given":"Anna-Marie B","family":"M\u00fcnster","sequence":"additional","affiliation":[{"name":"Unit for Thrombosis Research, University Hospital of Southern Denmark , 6700 Esbjerg , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"issue":"4","key":"2024031503434980700_dgad658-B1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2017-00212","article-title":"Klinefelter syndrome: integrating genetics, neuropsychology, and endocrinology","volume":"39","author":"Gravholt","year":"2018","journal-title":"Endocr Rev"},{"issue":"1","key":"2024031503434980700_dgad658-B2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1530\/EC-19-0433","article-title":"Klinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk","volume":"9","author":"Chang","year":"2019","journal-title":"Endocr Connect"},{"issue":"8","key":"2024031503434980700_dgad658-B3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1670639","article-title":"Anabolic androgenic steroid abuse: the effects on thrombosis risk, coagulation, and fibrinolysis","volume":"44","author":"Chang","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"2024031503434980700_dgad658-B4","doi-asserted-by":"crossref","first-page":"i5968","DOI":"10.1136\/bmj.i5968","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"2024031503434980700_dgad658-B5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cjco.2021.05.007","article-title":"The effect of testosterone on cardiovascular disease and cardiovascular risk factors in men: a review of clinical and preclinical data","volume":"3","author":"Kaur","year":"2021","journal-title":"CJC Open"},{"issue":"2","key":"2024031503434980700_dgad658-B6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ajmg.c.31798","article-title":"Morbidity in Klinefelter syndrome and the effect of testosterone treatment","volume":"184","author":"Chang","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"11","key":"2024031503434980700_dgad658-B7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jcem-2-11-615","article-title":"Albright F. Syndrome characterized by gynecomastia, aspermatogenesis without A-Leydigism, and increased excretion of follicle-stimulating hormone","volume":"2","author":"Klinefelter","year":"1942","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024031503434980700_dgad658-B8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2024031503434980700_dgad658-B9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2024031503434980700_dgad658-B10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/ATVBAHA.110.213371","article-title":"Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences","volume":"31","author":"Smalberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024031503434980700_dgad658-B11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.thromres.2019.08.011","article-title":"Testosterone treatment and association with thrombin generation and coagulation inhibition in Klinefelter syndrome: A cross-sectional study","volume":"182","author":"Chang","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"2024031503434980700_dgad658-B12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/andr.13330","article-title":"Platelet aggregation in Klinefelter syndrome is not aggravated by testosterone replacement therapy: A longitudinal follow-up study","volume":"11","author":"Chang","year":"2022","journal-title":"Andrology"},{"issue":"5):","key":"2024031503434980700_dgad658-B13","first-page":"e210490","article-title":"Reduced fibrin clot lysis in Klinefelter syndrome associated with hypogonadism","volume":"11","author":"Chang","year":"2022","journal-title":"Endocr Connect"},{"issue":"4","key":"2024031503434980700_dgad658-B14","doi-asserted-by":"crossref","first-page":"e1660","DOI":"10.1210\/clinem\/dgaa936","article-title":"Procoagulant imbalance in klinefelter syndrome assessed by thrombin generation assay and whole-blood thromboelastometry","volume":"106","author":"Indirli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024031503434980700_dgad658-B15","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.1038\/s41598-018-31780-0","article-title":"DNA Hypermethylation and differential gene expression associated with Klinefelter syndrome","volume":"8","author":"Skakkeb\u00e6k","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"2024031503434980700_dgad658-B16","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1073\/pnas.1910003117","article-title":"Integrated functional genomic analyses of Klinefelter and Turner syndromes reveal global network effects of altered X chromosome dosage","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"2024031503434980700_dgad658-B17","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 Risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"2024031503434980700_dgad658-B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-023-01169-4","article-title":"X chromosome dosage and the genetic impact across human tissues","volume":"15","author":"Viuff","year":"2023","journal-title":"Genome Med"},{"issue":"4","key":"2024031503434980700_dgad658-B19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"issue":"2","key":"2024031503434980700_dgad658-B20","doi-asserted-by":"crossref","first-page":"e1007664","DOI":"10.1371\/journal.pcbi.1007664","article-title":"Tximeta: reference sequence checksums for provenance identification in RNA-seq","volume":"16","author":"Love","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"2024031503434980700_dgad658-B21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"2024031503434980700_dgad658-B22","doi-asserted-by":"crossref","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","article-title":"A general framework for weighted gene co-expression network analysis","volume":"4","author":"Zhang","year":"2005","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2024031503434980700_dgad658-B23","author":"Chang"},{"issue":"19","key":"2024031503434980700_dgad658-B24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.109.863241","article-title":"Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study","volume":"120","author":"Severinsen","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"2024031503434980700_dgad658-B25","doi-asserted-by":"crossref","first-page":"e027502","DOI":"10.1161\/JAHA.122.027502","article-title":"Sex-specific risk factors for deep venous thrombosis and pulmonary embolism in a population-based historical cohort study of middle-aged and older individuals","volume":"12","author":"Brink","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2024031503434980700_dgad658-B26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metab Clin Exp"},{"issue":"4","key":"2024031503434980700_dgad658-B27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1160\/TH16-10-0748","article-title":"Fibrin clot structure\u2014pro-fibrinolytic effect of oral contraceptives in apparently healthy women","volume":"117","author":"Sidelmann","year":"2017","journal-title":"Thromb Haemost"},{"issue":"15","key":"2024031503434980700_dgad658-B28","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2010.32.8294","article-title":"Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study","volume":"29","author":"Ay","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"2024031503434980700_dgad658-B29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","article-title":"High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2024031503434980700_dgad658-B30","doi-asserted-by":"crossref","first-page":"e220455","DOI":"10.1530\/EC-22-0455","article-title":"Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study","volume":"12","author":"B\u00f8gehave","year":"2023","journal-title":"Endocr Connect"},{"issue":"0 1","key":"2024031503434980700_dgad658-B31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1538-7836.2009.03410.x","article-title":"The protein C pathway and pathologic processes","volume":"7 Suppl 1","author":"Castellino","year":"2009","journal-title":"J Thromb Haemos"},{"issue":"3","key":"2024031503434980700_dgad658-B32","first-page":"341","article-title":"Leg ulcers in Klinefelter's Syndrome\u2014further evidence for an involvement of plasminogen activator inhibitor-1","volume":"136","author":"Zollner","year":"1997","journal-title":"Br J Dermatol"},{"issue":"2","key":"2024031503434980700_dgad658-B33","first-page":"115","article-title":"Hypostatic leg ulceration and Klinefelter's Syndrome","volume":"24","author":"Campbell","year":"1980","journal-title":"J Ment Defic Res"},{"issue":"3","key":"2024031503434980700_dgad658-B34","doi-asserted-by":"crossref","first-page":"E518","DOI":"10.1210\/jc.2014-2780","article-title":"Gene expression patterns in relation to the clinical phenotype in Klinefelter syndrome","volume":"100","author":"Zitzmann","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024031503434980700_dgad658-B35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2133.1994.tb13112.x","article-title":"Increased plasma activity of plasminogen activator inhibitor 1 (PAI-1) in two patients with Klinefelter's Syndrome complicated by leg ulcers","volume":"130","author":"Veraart","year":"1994","journal-title":"Br J Dermatol"},{"issue":"10","key":"2024031503434980700_dgad658-B36","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","article-title":"Mechanisms of fibrin polymerization and clinical implications","volume":"121","author":"Weisel","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2024031503434980700_dgad658-B37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jth.12455","article-title":"The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis","volume":"12","author":"Hethershaw","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2024031503434980700_dgad658-B38","doi-asserted-by":"crossref","first-page":"e1503","DOI":"10.1002\/mgg3.1503","article-title":"Identification of common differentially expressed genes in Turner (45,X) and Klinefelter (47,XXY) syndromes using bioinformatics analysis","volume":"8","author":"Manotas","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"Pt 2","key":"2024031503434980700_dgad658-B39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1113\/jphysiol.2002.036616","article-title":"Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome","volume":"548","author":"Hittel","year":"2003","journal-title":"J Physiol"},{"issue":"2","key":"2024031503434980700_dgad658-B40","doi-asserted-by":"crossref","first-page":"101526","DOI":"10.1016\/j.jbc.2021.101526","article-title":"Structure and function of the ecto-nucleotide pyrophosphatase\/phosphodiesterase (ENPP) family: tidying up diversity","volume":"298","author":"Borza","year":"2022","journal-title":"J Biol Chem"},{"issue":"22","key":"2024031503434980700_dgad658-B41","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2012-04-425215","article-title":"NPP4 Is a procoagulant enzyme on the surface of vascular endothelium","volume":"120","author":"Albright","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2024031503434980700_dgad658-B42","first-page":"2927","article-title":"ENPP4 Overexpression is associated with no recovery from Barrett's Esophagus","volume":"13","author":"Wang","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"2024031503434980700_dgad658-B43","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1074\/jbc.M113.505867","article-title":"Molecular basis of purinergic signal metabolism by ectonucleotide pyrophosphatase\/phosphodiesterases 4 and 1 and implications in stroke","volume":"289","author":"Albright","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"2024031503434980700_dgad658-B44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11302-012-9303-x","article-title":"P2y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells","volume":"8","author":"Gachet","year":"2012","journal-title":"Purinergic Signal"},{"issue":"2","key":"2024031503434980700_dgad658-B45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1597283","article-title":"Platelet-mediated modulation of fibrinolysis","volume":"43","author":"Whyte","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"2024031503434980700_dgad658-B46","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.3390\/ijms22105135","article-title":"Fibrinolysis in platelet thrombi","volume":"22","author":"Kanji","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024031503434980700_dgad658-B47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/molehr\/gaq015","article-title":"Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's Syndrome","volume":"16","author":"Di Mambro","year":"2010","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"2024031503434980700_dgad658-B48","first-page":"378","article-title":"Triglyceride-glucose index levels in patients with Klinefelter syndrome and its relationship with endothelial dysfunction and insulin resistance: a cross-sectional observational study","volume":"67","author":"Demirci","year":"2023","journal-title":"Arch Endocrinol Metab"},{"issue":"1-2","key":"2024031503434980700_dgad658-B49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-007-9579-2","article-title":"Fibrinogen induces endothelial cell permeability","volume":"307","author":"Tyagi","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"2024031503434980700_dgad658-B50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2016.10.017","article-title":"Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?","volume":"60","author":"Ellins","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"1-2","key":"2024031503434980700_dgad658-B51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mce.2006.11.015","article-title":"The gonadotropins: tissue-specific angiogenic factors?","volume":"269","author":"Reisinger","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2024031503434980700_dgad658-B52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jth.15549","article-title":"Gonadotropins as novel active partners in vascular diseases: insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells","volume":"20","author":"D\u00e9trich\u00e9","year":"2022","journal-title":"J Thromb Haemost"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad658\/53929575\/dgad658.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/4\/978\/56950157\/dgad658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/4\/978\/56950157\/dgad658.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T03:44:59Z","timestamp":1710474299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/4\/978\/7420187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,14]]},"published-print":{"date-parts":[[2024,3,15]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad658","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2023,11,14]]}}}